Lexicon Pharmaceuticals, Inc.
Pharmaceutical company · The Woodlands, Texas, United States · Nasdaq: LXRX
Lexicon Pharmaceuticals, Inc. is a pharmaceutical company headquartered in The Woodlands, Texas, United States. Its shares trade on Nasdaq under the ticker LXRX. It has reported private securities offerings to the US SEC, most recently $56 million sold in a notice filed in 2026.
Lexicon Pharmaceuticals at a glance
What does Lexicon Pharmaceuticals do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $55.7 million sold (2026).
Frequently asked questions about Lexicon Pharmaceuticals
Where is Lexicon Pharmaceuticals headquartered?
Lexicon Pharmaceuticals, Inc. is headquartered in The Woodlands, Texas, United States.
What does Lexicon Pharmaceuticals do?
Lexicon Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Lexicon Pharmaceuticals a public company?
Yes. Lexicon Pharmaceuticals, Inc. trades on Nasdaq under the ticker LXRX.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.